Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via EAHP
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via EAHP
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 30, Issue Suppl 1
4CPS-209 Experience of the nocebo effect in patients with switch to biosimilars in rheumatoid arthritis
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Section 4: Clinical pharmacy services
4CPS-209 Experience of the nocebo effect in patients with switch to biosimilars in rheumatoid arthritis
Free
Online download statistics by month:
Online download statistics by month: March 2023 to September 2024
Abstract
Full
Pdf
Mar 2023
22
0
3
Apr 2023
43
0
9
May 2023
34
0
4
Jun 2023
17
0
3
Jul 2023
12
0
2
Aug 2023
10
0
0
Sep 2023
14
0
8
Oct 2023
8
0
2
Nov 2023
15
0
5
Dec 2023
13
0
2
Jan 2024
17
0
1
Feb 2024
22
0
4
Mar 2024
14
0
9
Apr 2024
2
0
0
May 2024
10
0
3
Jun 2024
4
0
0
Jul 2024
4
0
2
Aug 2024
10
0
7
Sep 2024
3
0
2
Total
274
0
66
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via EAHP
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF